Evidence map›Paper›PMID 40885972›Full record

ArticleJournal of nanobiotechnology2025

Defect-engineered amorphous-like nanointerceptors for T

Xiaotong Ma, Xin Liang, Yixin Yu, Hao Guan, Xuejiao Gao, Jing Li, Shanyue Guan, Aihua Liu, Li Yao, Kelong Fan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaotong MaKey Laboratory of Biomechanics and Mechanobiology, Key Laboratory of Innovation and Transformation of Advanced Medical Devices, Ministry of Industry and Information Technology, National Medical Innovation Platform for Industry-Education Integration in Advanced Medical Devices (Interdiscipline of Medicine and Engineering), School of Biological Science and Medical Engineering, Beihang University, Ministry of Education, Beihang University, Beijing, 100191, China.
Xin LiangBeijing Neurosurgical Institute, Beijing Tiantan Hospital, National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, 100070, China.
Yixin YuCAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules (CAS), CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, P. R. China.
Hao GuanBeijing Neurosurgical Institute, Beijing Tiantan Hospital, National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, 100070, China.
Xuejiao GaoCollege of Chemistry and Materials, Jiangxi Normal University, 330022, Nanchang, China.
Jing LiDepartment of Neurointervention, Henan Provincial Neurointerventional Engineering Research Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
Shanyue GuanKey Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, 100190, P. R. China. guanshanyue@mail.ipc.ac.cn.
Aihua LiuKey Laboratory of Biomechanics and Mechanobiology, Key Laboratory of Innovation and Transformation of Advanced Medical Devices, Ministry of Industry and Information Technology, National Medical Innovation Platform for Industry-Education Integration in Advanced Medical Devices (Interdiscipline of Medicine and Engineering), School of Biological Science and Medical Engineering, Beihang University, Ministry of Education, Beihang University, Beijing, 100191, China. liuaihuadoctor@163.com.
Li YaoDepartment of Neurology, XD Group Hospital, Xi'an, 710077, Shaanxi, China. yaoli1@um.gt.cn.
Kelong FanCAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules (CAS), CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, P. R. China. fankelong@ibp.ac.cn.

Funding

Ningxia Key Scientific and Technological Achievements Transformation Project 2024CJE09005
6 · The paper itself

Abstract

Ischemic reperfusion (I/R) injury is dominated by excessive reactive oxygen species (ROS)-mediated oxidative damage and uncontrolled inflammation, yet effective strategies for simultaneous diagnosis and treatment remain elusive. Herein, we report a defect-engineered amorphous-like MnCeO

Indexed as

NanoparticlesReperfusion InjuryAnimalsAntioxidantsCatalysisCell LineCell SurvivalCeriumMagnetic Resonance ImagingManganese CompoundsOxidative StressRatsReactive Oxygen SpeciesAntioxidantsceric oxideCeriumManganese CompoundsReactive Oxygen SpeciesAntioxidative nanozymeOxygen vacanciesReperfusion injuryT2-weighted MRI

Identifiers

PMID40885972
PMCPMC12398121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.